Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-SMNDC1 (1-238) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
SMNDC1 |
Gene ID: |
10285 |
Uniprot ID: |
SPF30_HUMAN |
Immunogen Region: |
1-238 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-238 of human SMNDC1 (NP_005862.1). |
Immunogen Sequence: |
MSEDLAKQLASYKAQLQQVE AALSGNGENEDLLKLKKDLQ EVIELTKDLLSTQPSETLAS SDSFASTQPTHSWKVGDKCM AVWSEDGQCYEAEIEEIDEE NGTAAITFAGYGNAEVTPLL NLKPVEEGRKAKEDSGNKPM SKKEMIAQQREYKKKKALKK AQRIKELEQEREDQKVKWQQ FNNRAYSKNKKGQVKRSIFA SPESVTGKVGVGTCGIADKP MTQYQDTSKYNVRHLMPQ |
Tissue Specificity | Detected at intermediate levels in skeletal muscle, and at low levels in heart and pancreas. |
Function | Involved in spliceosome assembly. |
Protein Name | Survival Of Motor Neuron-Related-Splicing Factor 3030 Kda Splicing Factor SmnrpSmn-Related ProteinSurvival Motor Neuron Domain-Containing Protein 1 |
Database Links | Reactome: R-HSA-72163 |
Cellular Localisation | Nucleus SpeckleNucleusCajal BodyDetected In Nuclear Speckles Containing Snrnp And In Cajal (Coiled) Bodies |
Alternative Antibody Names | Anti-Survival Of Motor Neuron-Related-Splicing Factor 30 antibodyAnti-30 Kda Splicing Factor Smnrp antibodyAnti-Smn-Related Protein antibodyAnti-Survival Motor Neuron Domain-Containing Protein 1 antibodyAnti-SMNDC1 antibodyAnti-SMNR antibodyAnti-SPF30 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance